These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Present status of studies on the treatment of choroidal neovascularization by Anecortave acetate]. Li X; Wang YS Zhonghua Yan Ke Za Zhi; 2008 Jun; 44(6):571-4. PubMed ID: 19035252 [TBL] [Abstract][Full Text] [Related]
7. First clinical experience with anecortave acetate (Retaane). Hayek S; Scherrer M; Barthelmes D; Fleischhauer JC; Kurz-Levin MM; Menghini M; Helbig H; Sutter FK Klin Monbl Augenheilkd; 2007 Apr; 224(4):279-81. PubMed ID: 17458792 [TBL] [Abstract][Full Text] [Related]
8. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD]. Pauleikhoff D; Bornfeld N; Gabel VP; Holz F; Roider H; ; ; Klin Monbl Augenheilkd; 2005 May; 222(5):381-8. PubMed ID: 15912454 [TBL] [Abstract][Full Text] [Related]
9. Anecortave acetate for fibrotic lesions with presence of residual peripheral activity in age-related macular degeneration. Aggermann T; Haas P; Binder S Ann Ophthalmol (Skokie); 2008; 40(1):28-30. PubMed ID: 18556978 [TBL] [Abstract][Full Text] [Related]
10. [Is there a drug therapy for age-related macular degeneration?--current status and new therapeutic approaches]. Augustin AJ; Offermann I Klin Monbl Augenheilkd; 2008 Jun; 225(6):555-63. PubMed ID: 18516776 [TBL] [Abstract][Full Text] [Related]
11. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Wilson HL; Schwartz DM; Bhatt HR; McCulloch CE; Duncan JL Am J Ophthalmol; 2004 Apr; 137(4):615-24. PubMed ID: 15059698 [TBL] [Abstract][Full Text] [Related]
17. Emerging therapies for neovascular age-related macular degeneration: state of the art. Donati G Ophthalmologica; 2007; 221(6):366-77. PubMed ID: 17947822 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study. Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341 [TBL] [Abstract][Full Text] [Related]
19. Computerized model of cost-utility analysis for treatment of age-related macular degeneration. Fletcher EC; Lade RJ; Adewoyin T; Chong NV Ophthalmology; 2008 Dec; 115(12):2192-8. PubMed ID: 18930556 [TBL] [Abstract][Full Text] [Related]
20. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Ferrara N; Damico L; Shams N; Lowman H; Kim R Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]